Astarita, A.; Mingrone, G.; Airale, L.; Colomba, A.; Catarinella, C.; Cesareo, M.; Vallelonga, F.; Paladino, A.; Bruno, G.; Leone, D.;
et al. Validation of the HFA-ICOS Score for Carfilzomib-Induced Cardiotoxicity in Multiple Myeloma: A Real-Life Perspective Study. Cancers 2025, 17, 2353.
https://doi.org/10.3390/cancers17142353
AMA Style
Astarita A, Mingrone G, Airale L, Colomba A, Catarinella C, Cesareo M, Vallelonga F, Paladino A, Bruno G, Leone D,
et al. Validation of the HFA-ICOS Score for Carfilzomib-Induced Cardiotoxicity in Multiple Myeloma: A Real-Life Perspective Study. Cancers. 2025; 17(14):2353.
https://doi.org/10.3390/cancers17142353
Chicago/Turabian Style
Astarita, Anna, Giulia Mingrone, Lorenzo Airale, Anna Colomba, Cinzia Catarinella, Marco Cesareo, Fabrizio Vallelonga, Arianna Paladino, Giulia Bruno, Dario Leone,
and et al. 2025. "Validation of the HFA-ICOS Score for Carfilzomib-Induced Cardiotoxicity in Multiple Myeloma: A Real-Life Perspective Study" Cancers 17, no. 14: 2353.
https://doi.org/10.3390/cancers17142353
APA Style
Astarita, A., Mingrone, G., Airale, L., Colomba, A., Catarinella, C., Cesareo, M., Vallelonga, F., Paladino, A., Bruno, G., Leone, D., Gay, F., Bringhen, S., Veglio, F., & Milan, A.
(2025). Validation of the HFA-ICOS Score for Carfilzomib-Induced Cardiotoxicity in Multiple Myeloma: A Real-Life Perspective Study. Cancers, 17(14), 2353.
https://doi.org/10.3390/cancers17142353